170 related articles for article (PubMed ID: 34581019)
61. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
Yalcin TE; Ilbasmis-Tamer S; Takka S
Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
[TBL] [Abstract][Full Text] [Related]
62. Physicochemical and in vitro cytotoxicity studies of inclusion complex between gemcitabine and cucurbit[7]uril host.
Buczkowski A; Gorzkiewicz M; Stepniak A; Malinowska-Michalak M; Tokarz P; Urbaniak P; Ionov M; Klajnert-Maculewicz B; Palecz B
Bioorg Chem; 2020 Jun; 99():103843. PubMed ID: 32305692
[TBL] [Abstract][Full Text] [Related]
63. Gemcitabine and γ-cyclodextrin/docetaxel inclusion complex-loaded liposome for highly effective combinational therapy of osteosarcoma.
Sun L; Zhou DS; Zhang P; Li QH; Liu P
Int J Pharm; 2015 Jan; 478(1):308-317. PubMed ID: 25433201
[TBL] [Abstract][Full Text] [Related]
64. Local release of gemcitabine via in situ UV-crosslinked lipid-strengthened hydrogel for inhibiting osteosarcoma.
Wu W; Dai Y; Liu H; Cheng R; Ni Q; Ye T; Cui W
Drug Deliv; 2018 Nov; 25(1):1642-1651. PubMed ID: 30799654
[TBL] [Abstract][Full Text] [Related]
65. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Xu J; Guo W; Xie L
BMC Cancer; 2018 Oct; 18(1):987. PubMed ID: 30326879
[TBL] [Abstract][Full Text] [Related]
66. Micellar nanoparticles loaded with gemcitabine and doxorubicin showed synergistic effect.
Liu D; Chen Y; Feng X; Deng M; Xie G; Wang J; Zhang L; Liu Q; Yuan P
Colloids Surf B Biointerfaces; 2014 Jan; 113():158-68. PubMed ID: 24077114
[TBL] [Abstract][Full Text] [Related]
67. Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.
Arya G; Vandana M; Acharya S; Sahoo SK
Nanomedicine; 2011 Dec; 7(6):859-70. PubMed ID: 21550422
[TBL] [Abstract][Full Text] [Related]
68. Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.
Li L; Tong R; Li M; Kohane DS
Acta Biomater; 2016 Mar; 33():34-9. PubMed ID: 26826531
[TBL] [Abstract][Full Text] [Related]
69. 12b80 - Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma.
David E; Cagnol S; Goujon JY; Egorov M; Taurelle J; Benesteau C; Morandeau L; Moal C; Sicard M; Pairel S; Heymann D; Redini F; Gouin F; Le Bot R
Bioconjug Chem; 2019 Jun; 30(6):1665-1676. PubMed ID: 31045351
[TBL] [Abstract][Full Text] [Related]
70. A novel multifunctional carbon aerogel-coated platform for osteosarcoma therapy and enhanced bone regeneration.
Dong S; Zhang YN; Wan J; Cui R; Yu X; Zhao G; Lin K
J Mater Chem B; 2020 Jan; 8(3):368-379. PubMed ID: 31782474
[TBL] [Abstract][Full Text] [Related]
71. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
[TBL] [Abstract][Full Text] [Related]
72. Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.
Cosco D; Rocco F; Ceruti M; Vono M; Fresta M; Paolino D
Int J Nanomedicine; 2012; 7():2535-46. PubMed ID: 22679366
[TBL] [Abstract][Full Text] [Related]
73. Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor.
Valetti S; Maione F; Mura S; Stella B; Desmaële D; Noiray M; Vergnaud J; Vauthier C; Cattel L; Giraudo E; Couvreur P
J Control Release; 2014 Oct; 192():29-39. PubMed ID: 24984010
[TBL] [Abstract][Full Text] [Related]
74. Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma.
Wu L; Zhang F; Chen X; Wan J; Wang Y; Li T; Wang H
ACS Appl Mater Interfaces; 2020 Jan; 12(3):3327-3340. PubMed ID: 31872760
[TBL] [Abstract][Full Text] [Related]
75. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
Koshkina NV; Kleinerman ES
Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
[TBL] [Abstract][Full Text] [Related]
76. Discovery of a novel chimeric ubenimex-gemcitabine with potent oral antitumor activity.
Jiang Y; Hou J; Li X; Huang Y; Wang X; Wu J; Zhang J; Xu W; Zhang Y
Bioorg Med Chem; 2016 Nov; 24(22):5787-5795. PubMed ID: 27670098
[TBL] [Abstract][Full Text] [Related]
77. Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience.
He A; Qi W; Huang Y; Sun Y; Shen Z; Zhao H; Yang Y; Yao Y
Int J Clin Oncol; 2013 Jun; 18(3):498-505. PubMed ID: 22534798
[TBL] [Abstract][Full Text] [Related]
78. Selective Activation of a Prodrug by Thioredoxin Reductase Providing a Strategy to Target Cancer Cells.
Li X; Hou Y; Meng X; Ge C; Ma H; Li J; Fang J
Angew Chem Int Ed Engl; 2018 May; 57(21):6141-6145. PubMed ID: 29582524
[TBL] [Abstract][Full Text] [Related]
79. Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study.
Merimsky O; Meller I; Flusser G; Kollender Y; Issakov J; Weil-Ben-Arush M; Fenig E; Neuman G; Sapir D; Ariad S; Inbar M
Cancer Chemother Pharmacol; 2000; 45(2):177-81. PubMed ID: 10663634
[TBL] [Abstract][Full Text] [Related]
80. Silica nanoparticle conjugation with gallic acid towards enhanced free radical scavenging capacity and activity on osteosarcoma cells
Hohagen M; Saraiva N; Kählig H; Gerner C; Del Favero G; Kleitz F
J Mater Chem B; 2024 Jul; 12(26):6424-6441. PubMed ID: 38860306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
